Mark Blum, Managing Director of the PBM Accountability Project, issued a statement about the Senate Commerce Committee progress on the Pharmacy Benefit Manager Transparency Act. He states that other Congressional committees share important responsibility for assuring affordability of prescription drugs, and that those other committees must do their part to truly hold PBMs accountable. Read the full statement here.
top of page
bottom of page